P&G's Weak FY26 Results Reinforce Hold Rating Amid Thin Margin of Safety

What happened

Seeking Alpha's latest article on P&G reiterates a Hold rating, citing weak FY26 results with just 1% organic sales and Core EPS growth, and FY27 guidance of only 1-3% organic sales growth. This corroborates the DeepValue master report's WAIT rating, which observed flat organic sales and a 200bps operating margin decline in FQ2'26, driven by mix, tariffs, and reinvestment overshadowing productivity gains. The article highlights a $1 billion after-tax headwind and rising private label competition, which aligns with the master report's identified risks of promotional intensity and share losses in key categories like Fabric and Baby care. Despite strong free cash flow and a ~3% dividend yield, both sources agree that the current valuation offers limited margin of safety, with the master report's base case implied value of $155 leaving little upside from recent prices. The combined evidence suggests P&G's defensive qualities are intact, but near-term growth and margin challenges warrant a patient stance until clearer signs of operating leverage emerge.

Implication

The latest FY26 results confirm that P&G's organic growth has stalled at around 1%, with FY27 guidance of only 1-3% suggesting limited near-term acceleration. Margin pressures from tariffs, mix shifts, and necessary price investments are unlikely to abate quickly, keeping operating margin near the recent 24% level. While the company's strong free cash flow and dividend yield provide downside support, the lack of margin of safety at current valuation levels argues against new positions. The master report's base case of $155 implies only modest upside, while its bear case of $135 highlights the risk if promotional activity intensifies further. Investors should wait for evidence that productivity gains are translating into operating margin expansion and that volume declines have stabilized before reconsidering the stock.

Thesis delta

The thesis is unchanged: P&G remains a quality compounder but is priced without a margin of safety. The new FY26 results showing only 1% organic growth and FY27 guidance of 1-3% are slightly below the master report's base case expectations, reinforcing the need for patience. The $1 billion after-tax headwind disclosed adds a new quantifiable risk, but it does not alter the WAIT rating.